{"id":"https://openalex.org/W2012630248","doi":"https://doi.org/10.1056/nejmc0808527","title":"Eculizumab for Atypical Hemolytic\u2013Uremic Syndrome","display_name":"Eculizumab for Atypical Hemolytic\u2013Uremic Syndrome","publication_year":2009,"publication_date":"2009-01-28","ids":{"openalex":"https://openalex.org/W2012630248","doi":"https://doi.org/10.1056/nejmc0808527","mag":"2012630248","pmid":"https://pubmed.ncbi.nlm.nih.gov/19179328"},"language":"en","primary_location":{"id":"doi:10.1056/nejmc0808527","doi":"https://doi.org/10.1056/nejmc0808527","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmc0808527","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMc0808527?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMc0808527?articleTools=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012332362","display_name":"Jens N\u00fcrnberger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jens N\u00fcrnberger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113583104","display_name":"Thomas Philipp","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Philipp","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087456839","display_name":"Oliver Witzke","orcid":"https://orcid.org/0000-0002-1019-1301","observed_orcids":["https://orcid.org/0000-0002-1019-1301"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oliver Witzke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111671034","display_name":"Anabelle M. Opazo Saez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anabelle Opazo Saez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054261566","display_name":"Udo Vester","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Udo Vester","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052731204","display_name":"Hideo Andreas Baba","orcid":"https://orcid.org/0000-0002-1750-5318","observed_orcids":["https://orcid.org/0000-0002-1750-5318"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hideo Andreas Baba","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050533188","display_name":"Andreas Kribben","orcid":"https://orcid.org/0000-0003-4859-7507","observed_orcids":["https://orcid.org/0000-0003-4859-7507"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andreas Kribben","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056490986","display_name":"Lothar Bernd Zimmerhackl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lothar Bernd Zimmerhackl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065706727","display_name":"Andreas Janecke","orcid":"https://orcid.org/0000-0001-7155-0315","observed_orcids":["https://orcid.org/0000-0001-7155-0315"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andreas R. Janecke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113859155","display_name":"Mato Nagel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mato Nagel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5067373544","display_name":"Michael Kirschfink","orcid":"https://orcid.org/0000-0002-5364-7532","observed_orcids":["https://orcid.org/0000-0002-5364-7532"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Kirschfink","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":20.2575,"has_fulltext":true,"cited_by_count":347,"citation_normalized_percentile":{"value":0.99635395,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"360","issue":"5","first_page":"542","last_page":"544"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atypical-hemolytic-uremic-syndrome","display_name":"atypical hemolytic uremic syndrome","score":0.9309999942779541},{"id":"https://openalex.org/keywords/eculizumab","display_name":"eculizumab","score":1.0},{"id":"https://openalex.org/keywords/complement-inhibition","display_name":"complement inhibition","score":0.9649999737739563},{"id":"https://openalex.org/keywords/complement-c5","display_name":"complement C5","score":0.6930000185966492},{"id":"https://openalex.org/keywords/monoclonal-antibody-therapy","display_name":"monoclonal antibody therapy","score":0.7710000276565552},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.8259999752044678}],"concepts":[{"id":"https://openalex.org/C2777991916","wikidata":"https://www.wikidata.org/wiki/Q421617","display_name":"Eculizumab","level":4,"score":0.9492857456207275},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9440082311630249},{"id":"https://openalex.org/C2777637130","wikidata":"https://www.wikidata.org/wiki/Q17165460","display_name":"Atypical hemolytic uremic syndrome","level":4,"score":0.9390919208526611},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3878861963748932},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3735613524913788},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3614787757396698},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.21577924489974976},{"id":"https://openalex.org/C111684460","wikidata":"https://www.wikidata.org/wiki/Q334848","display_name":"Complement system","level":3,"score":0.2053399384021759}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003180","descriptor_name":"Complement C3b Inactivator Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D003182","descriptor_name":"Complement C5","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006463","descriptor_name":"Hemolytic-Uremic Syndrome","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006463","descriptor_name":"Hemolytic-Uremic Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006463","descriptor_name":"Hemolytic-Uremic Syndrome","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016030","descriptor_name":"Kidney Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017242","descriptor_name":"Complement Factor H","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D017384","descriptor_name":"Sequence Deletion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020125","descriptor_name":"Mutation, Missense","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1056/nejmc0808527","doi":"https://doi.org/10.1056/nejmc0808527","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmc0808527","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMc0808527?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},{"id":"pmid:19179328","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19179328","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.1056/nejmc0808527","doi":"https://doi.org/10.1056/nejmc0808527","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmc0808527","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMc0808527?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2012630248.pdf","grobid_xml":"https://content.openalex.org/works/W2012630248.grobid-xml"},"referenced_works_count":4,"referenced_works":["https://openalex.org/W2067053006","https://openalex.org/W2091338738","https://openalex.org/W2098383030","https://openalex.org/W2152757679"],"related_works":["https://openalex.org/W2316289546","https://openalex.org/W2184531469","https://openalex.org/W1493815334","https://openalex.org/W2141534367","https://openalex.org/W2565202172","https://openalex.org/W2557854875","https://openalex.org/W2149330659","https://openalex.org/W2076696472","https://openalex.org/W2001808603","https://openalex.org/W2037516600"],"abstract_inverted_index":{"To":[0],"the":[1,47,89,95,98],"Editor:":[2],"Atypical":[3],"hemolytic\u2013uremic":[4,51,70],"syndrome":[5,33,71],"is":[6],"a":[7,15,66,78],"disease":[8],"of":[9,29,49,68,88,97],"uncontrolled":[10],"complement":[11,39,84,90],"activation":[12],"associated":[13],"with":[14,31,76],"high":[16],"mortality":[17],"rate,":[18],"and":[19],"most":[20],"cases":[21],"progress":[22],"to":[23],"end-stage":[24],"renal":[25],"disease.1":[26],"About":[27],"50%":[28],"patients":[30],"this":[32,58],"carry":[34],"mutations":[35],"in":[36],"genes":[37],"encoding":[38],"proteins.2":[40],"Complement":[41],"inhibition":[42],"has":[43],"been":[44],"suggested":[45],"for":[46],"treatment":[48,59],"atypical":[50,69],"syndrome,3":[52],"but":[53],"currently":[54],"no":[55],"data":[56],"on":[57,65],"option":[60],"are":[61],"available.":[62],"We":[63],"report":[64],"case":[67],"that":[72,82],"was":[73],"successfully":[74],"treated":[75],"eculizumab,":[77],"humanized":[79],"monoclonal":[80],"antibody":[81],"blocks":[83],"activity":[85],"by":[86],"cleavage":[87],"protein":[91],"C5,":[92],"thereby":[93],"preventing":[94],"generation":[96],"inflammatory":[99],".\u00a0.\u00a0.":[100]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":13},{"year":2016,"cited_by_count":25},{"year":2015,"cited_by_count":23},{"year":2014,"cited_by_count":39},{"year":2013,"cited_by_count":31},{"year":2012,"cited_by_count":49}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}